Search Results 1401-1410 of 16396 for alt

1. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x ULN. Thyroid stimulating hormone (TSH) within normal limits (TSH < ULN allowed in ...

2. Testing Proton Craniospinal Radiation Therapy Versus The Usual Radiation Therapy For Leptomeningeal Metastasis, RADIATE-LM Trial - Mayo Clinic

   ... (ALT) (serum glutamic pyruvic transaminase [SGPT]) ≤ 3 × ULN * No prior radiation therapy to the spinal cord with equivalent dose in 2 gray (Gy) fractions ...

3. Novel Study Interventions and Combinations in Participants with Colorectal Cancer - Mayo Clinic

   Have normal transaminase values, or, if liver metastases are present, abnormal transaminases, with a result of AST/ALT < 3 × ULN, which are not attributable to ...

4. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   Adequate liver function, as defined by AST and ALT ≤ 3 x ULN, and bilirubin ≤ 1.5 x ULN (unless documented Gilbert's syndrome). INR and APTT ≤ 1.5 x ULN ...

5. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 x upper limit of normal (ULN) or ≤ 5 x ULN if liver metastases are present.

6. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) ≤ 3 x institutional ULN. No prior systemic therapy for the study cancer. No prior radiotherapy to the ...

7. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) ≤ 2.5 x ULN (≤ 3 x ULN for patients with liver metastases) (within 14 days prior ...

8. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   Inadequate hepatic function defined by AST and/or ALT > 2.5 × upper limit of normal (ULN) and total bilirubin > 1.5 × ULN (unless due to Gilbert's syndrome and ...

9. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   ... (ALT) > 3.0×ULN;; Subjects with both a creatinine > 1.5×ULN and an estimated creatinine clearance of < 60 mL/min (using the Cockcroft-Gault equation); ...

10. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

    - Total serum bilirubin ≤ 1.5 x upper limit of normal (ULN). - Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 2.5 x ULN (or ≤ 5 x ULN ...